Casdin Capital, LLC Alector, Inc. Transaction History

Casdin Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$13.02 - $20.78 $21.5 Million - $34.3 Million	-1,650,000 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$10.54 - $24.96 $6.05 Million - $14.3 Million	573,961 Added 53.34%	1,650,000 $17.4 Million
Q4 2019 Feb 14, 2020	BUY	$14.17 - $20.3 $3.76 Million - $5.38 Million	265,000 Added 32.67%	1,076,039 $18.5 Million
Q3 2019 Nov 12, 2019	BUY	$14.42 - $22.2 $3.75 Million - $5.77 Million	260,000 Added 47.18%	811,039 $11.7 Billion
Q2 2019 Aug 13, 2019	BUY	$16.26 - $26.42 $3.58 Million - $5.81 Million	220,000 Added 66.46%	551,039 $0
Q1 2019 May 15, 2019	BUY	$15.97 - $22.5 $5.29 Million - $7.45 Million	331,039 New	331,039 $6.2 Million

147

55.5M

56.4K

23.2K

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $104M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

Get notified when there are updates to the investment portfolio of Casdin Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Casdin Capital, LLC with notifications on news.